stockrow
Friday 6 November 2026
Export ALB’s income statement to Excel — free account
Albemarle Corporation
ALB Basic Materials Specialty Chemicals
Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024.
- Revenue
- +18.8%
- EPS
- +225.6%
- Free cash flow
- +708.4%
- Total debt
- −48.1%
Quarter to September 2026, against a year earlier
98.83
0.46
+0.47%
Follow ALB
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(8.73%) | (5.02%) | 0.69% | 6.20% | |
Piotroski F-Score |
6 | 6 | 7 | — | |
| (4.11%) | (2.49%) | 0.35% | 3.10% | ||
ROIC |
(2.02%) | (0.88%) | 1.46% | 3.55% | |
Return on Tangible Assets |
(6.26%) | (3.91%) | 0.55% | 4.76% | |
Average Days of Receivables |
49.58 | 43.81 | 44.96 | 44.57 | |
Free Cash Flow per Share |
6.16 | 5.16 | 11.46 | 0.00 | |
Free Cash Flow |
725.28 | 608.26 | 1,351.43 | — | |
Capital Expenditures |
(556.99) | (473.04) | (448.89) | — | |
| Other line items | |||||
Cash ROIC |
4.97% | 4.65% | 9.62% | 0.00% | |
Accounts Receivable Turnover |
6.13 | 7.49 | 7.35 | 7.73 | |
Accounts Payable Turnover |
4.82 | 4.84 | 4.56 | 0.00 | |
Inventory Turnover |
3.34 | 2.98 | 2.98 | 3.12 | |
Average Days of Payables |
74.53 | 76.06 | 90.47 | 0.00 | |
Days of Inventory on Hand |
96.21 | 109.71 | 112.28 | 111.39 | |
Tax Rate |
0.28 | 0.65 | (1.41) | (0.54) | |
Research and Development Expense of Revenue |
1.00% | 0.85% | 0.64% | 0.54% | |
Selling, General and Administrative Expense of Revenue |
10.70% | 10.26% | 9.44% | 9.03% | |
Share Based Compensation of Revenue |
0.78% | 0.75% | 0.64% | 0.59% | |
Interest Coverage |
(1.77) | (0.80) | 1.46 | 4.13 | |
Operating CF/Net income |
(1.89) | (2.71) | 31.35 | 0.00 | |
Depreciation/Fixed assets |
0.10 | 0.10 | 0.10 | 0.08 | |
Capex/Depreciation |
(0.66) | (0.57) | (0.55) | 0.00 | |
Revenue per Share |
43.71 | 46.62 | 50.08 | 52.14 | |
Operating CF per Share |
10.90 | 9.17 | 15.26 | 0.00 | |
Capex per Share |
(4.73) | (4.01) | (3.81) | 0.00 | |
Capex to Sales |
0.11 | 0.09 | 0.08 | 0.00 |
Columns are period end dates · fundamentals updated 4 Nov 2026